TSN
Click for more information
0.00% 1.0¢ the sustainable nutrition group ltd

News: Alchemia Limited in halt relating to profit share for anti-coagulant drug, page-2

  1. ivabiggon
    1,236 Posts.
    lightbulb Created with Sketch. 26
    clock Created with Sketch.
    25/05/15
    07:10
    Post #: 15342001
    Considering this from Proactive investor....Fondaparinux, a generic version of GlaxoSmithKline’s Arixtra, is FDA approved and targets the multi-billion dollar heparin-drug market.

    Multi Billion Dollar Heparin-drug market and we are scratching sround for a couple of mill. We really are getting right royally screwed from DRs. Let's hope we get some new blood in the company that can take these Indians to task.
    ACL Price at posting: 8.3¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 18  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Good debt vs bad debt for the property in your investment portfolio
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TSN (ASX) to my watchlist
(20min delay)
Last
1.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $1.409M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
TSN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.